SCHEMBL1851933

SCHEMBL1851933

NC(=O)c1cccc(-c2ccc(F)c3cc(Cc4cc(F)cc(Cl)c4)sc23)c1.O=C(O)c1cccc(-c2ccc(F)c3cc(Cc4cc(F)cc(Cl)c4)sc23)c1

nearest known ligand 0.53

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
GPR52 Q9Y2T5 4/20 0.53
PLA2G2A P14555 1/20 0.39
CLK1 P49759 1/20 0.39
METAP2 P50579 2/20 0.39
RXRA P19793 1/20 0.38
RXRB P28702 1/20 0.38
SHMT1 P34896 1/20 0.37
PTGER1 P34995 1/20 0.37
PARP1 P09874 1/20 0.36
AKR1C3 P42330 1/20 0.36
AKR1C2 P52895 1/20 0.36
FOLH1 Q04609 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3217370 0.96 GPR52 (0.56) GPR52CLK1METAP2SHMT1PARP1
SCHEMBL1849783 0.95 GPR52 (0.56) GPR52PLA2G2ARXRARXRBPTGER1
SCHEMBL1855888 0.94 GPR52 (0.52) GPR52PLA2G2ACLK1METAP2RXRA
SCHEMBL3206698 0.90 GPR52 (0.55) GPR52CLK1METAP2SHMT1PARP1
SCHEMBL1852756 0.89 GPR52 (0.56) GPR52PLA2G2ARXRARXRBPTGER1
SCHEMBL1851979 0.87 GPR52 (0.53) GPR52PTGER1AKR1C3AKR1C2NPC1
SCHEMBL1851422 0.86 GPR52 (0.49) GPR52RXRARXRBPTGER1AKR1C3
SCHEMBL3209104 0.85 GPR52 (0.72) GPR52CLK1METAP2
SCHEMBL13489633 0.84 GPR52 (0.46) GPR52METAP2PARP1
SCHEMBL1849572 0.84 GPR52 (0.71) GPR52RXRARXRBPTGER1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2323978-A1 AMIDE COMPOUND Takeda Pharmaceutical Company Limited (JP) 2011-05-25 EP disclosed
WO-2010018874-A1 AMIDE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-02-18 WO disclosed